Effect of a single dose of pregabalin on herpes zoster pain

Trials

Volumn 12, Issue , 2011, Pages

  Jensen Dahm, Christina ^a   Rowbotham, Michael C ^b   Reda, Haatem ^c   Petersen, Karin L ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; PREGABALIN; 4 AMINOBUTYRIC ACID; ANALGESIC AGENT; DRUG DERIVATIVE;

ADULT; AGED; ALLODYNIA; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HERPES ZOSTER; HUMAN; MALE; MCGILL PAIN QUESTIONNAIRE; NAUSEA; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOMNOLENCE; THINKING IMPAIRMENT; TREATMENT RESPONSE; UNSTEADINESS; VISUAL ANALOG SCALE; VOMITING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HYPERALGESIA; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; TREATMENT OUTCOME; UNITED STATES; VIROLOGY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; CALIFORNIA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HERPES ZOSTER; HUMANS; HYPERALGESIA; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT SELECTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952057642     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-55     Document Type: Article

References (8)

1. Berry JD, Petersen KL. A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology 2005, 65(3):444-7. 10.1212/01.WNL.0000168259.94991.8a, 16087911.
2. Taylor CP. Mechanisms of analgesia by gabapentin and pregabalin--calcium channel alpha2-delta [Cavalpha2-delta] ligands. Pain 2009, 142(1-2):13-6. 10.1016/j.pain.2008.11.019, 19128880.
3. Strand LI, Ljunggren AE, Bogen B, Ask T, Johnsen TB. The Short-Form McGill Pain Questionnaire as an outcome measure: test-retest reliability and responsiveness to change. Eur J Pain 2008, 12(7):917-25. 10.1016/j.ejpain.2007.12.013, 18289893.
4. Dworkin RH, Corbin AE, Young JP, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2003, 60(8):1274-83.
5. Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain 2008, 9(11):1006-17. 10.1016/j.jpain.2008.05.014, 18640074.
6. Dworkin RH, Barbano RL, Tyring SK, Betts RF, McDermott MP, Pennella-Vaughan J, Bennett GJ, Berber E, Gnann JW, Irvine C, Kamp C, Kieburtz K, Max MB, Schmader KE. A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain 2009, 142(3):209-17. 10.1016/j.pain.2008.12.022, 19195785.
7. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 2000, 321:794-6. 10.1136/bmj.321.7264.794, 27491, 11009518.
8. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352(22):2271-84. 10.1056/NEJMoa051016, 15930418.